Article
Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study period.
AIDS (London, England) - 31 Jul 2013
Kyeyune Fred, Nankya Immaculate, Metha Samar, Akao Juliet, Ndashimye Emmanuel, Tebit Denis M, Rodriguez Benigno, Kityo Cissy, Salata Robert A, Mugyenyi Peter, Arts Eric
Abstract excerpt
OBJECTIVES: To determine the impact of HIV-1 subtype on treatment outcomes and the emergence of drug resistance in the resource limited setting of Kampala, Uganda. DESIGN: The Joint Clinical Research Centre (JCRC) in Kampala, Uganda has provided over 2000 drug-resistant genotypes (DRGs) over the past 10 years as standard of care for patients failing therapy and 1403 from treatment-naive and experienced patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
